Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announces the completion of Labcorp’s acquisition of select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. This acquisition includes BioReference Health’s laboratory testing businesses focused on oncology and oncology-related clinical testing services across the United States. This transaction includes certain customer accounts and other operating assets. The purchase price for the transaction is up to $225 million, including $192.5 million that was paid at closing and up to $32.5 million in an earnout based on performance.
Read the full article: Labcorp Completes Acquisition of Select Assets of BioReference Health’s Innovative Oncology and Related Clinical Testing Services Businesses //
Source: https://www.prnewswire.com/news-releases/labcorp-completes-acquisition-of-select-assets-of-bioreference-healths-innovative-oncology-and-related-clinical-testing-services-businesses-302556302.html